Using Valacyclovir to Manage Pain from Acute Apical Abscesses
Official title: Role of Herpesviruses as a Causative Factor in Acute Apical Abscess
Run by University of California, San Francisco · NCT05266040 · Data updated 2026-11-12
This study tests if adding valacyclovir to antibiotics can help reduce pain for people with acute apical abscesses.
Quick facts
| Phase | Phase 2 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 80 Years |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | University of California, San Francisco Academic / other |
| Locations | 1 site (San Francisco, California) |
| Status | Recruiting |
| Started | October 25, 2023 |
| Main results expected | December 31, 2025 |
| Study ends | December 31, 2025 |
| Registry record updated | May 30, 2025 |
| Trial ID | NCT05266040 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older who are systemically healthy and exhibit signs of pulp necrosis with moderate to severe pain.
✕Probably not a fit
Patients with certain dental conditions, smokers, or those with allergies to the study medications may not benefit from this trial.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to evaluate the effectiveness of a treatment regimen combining valacyclovir and antibiotics for managing pain associated with acute apical abscesses. It will involve 250 participants who will be randomly assigned to receive either the combination treatment or antibiotics alone. Preoperative and postoperative imaging will be conducted using cone beam computed tomography (CBCT) to assess pain levels and healing outcomes. The study seeks to address the viral component of endodontic infections to improve patient outcomes.
Why it matters
Potential benefit: If successful, this treatment could significantly reduce pain and accelerate healing for patients suffering from acute apical abscesses.
How similar studies have gone: While this approach is innovative, it builds on preliminary findings from a pilot study, indicating potential for success but is not yet widely tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient must be ≥ 18-year-old * Patient must be systemically healthy; American Society of Anesthesiologists (ASA) Class I or II * Patient must exhibit clinical evidence of pulp necrosis and acute apical abscess * Patient must present with radiographic * signs of apical disease either by * periapical radiography or cone-beam * computed tomography * Patient consented to receive conventional pulpal debridement, incision and drainage at the end of the study * Persistent pain of moderate or higher level (\>4) was the main inclusion criterion. Pain assessed as follows: 0 defined as no pain, 1-3 as mild pain, 4-6 as moderate pain, and 7-10 as severe pain Exclusion Criteria: * Smokers (more than 10 cigarettes per day) * External or internal tooth resorption * Marginal periodontitis * Pregnant or nursing mothers (hormonal factors may influence the periapical condition) * Documented allergic or adverse reactions to amoxicillin or valacyclovir * Teeth with unusual anatomy or inaccurate clinical diagnosis on the day of treatment (i.e., partially necrotic pulp) * Patients currently taking antibiotics or antiviral medications
Where it's running
-
UCSF Dental
San Francisco, California, United States Recruiting
Study contacts
- Principal investigator: Mike Sabeti, DDS — University of California, San Francisco
- Study coordinator: Mike Sabeti, DDS
- Email: Mike.Sabeti@ucsf.edu
- Phone: 415-476-0822
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Antibacterial effects of two intracanal medicaments in acute apical abscesses
This randomized trial tests whether calcium hydroxide or a calcium silicate-based medicament more effectively lowers bacterial load in teeth with acute apical abscesses during a 7–10 day medication period.
-
SAM aluminium splint for suspected wrist fractures
This study will see if adding a SAM aluminium splint to usual care reduces pain for people with suspected wrist fractures who come to the emergency department.
-
Combined acupressure to reduce post-thoracotomy pain and improve lung volume
This trial will try combined acupressure on patients after thoracotomy to see if it reduces postoperative pain and helps restore lung volume.
-
Phase 1 testing of SBS-147 in healthy adults
This study will test if SBS-147 is safe and how healthy adults' bodies handle single or repeated doses compared with a placebo.
-
Butyrate and Taurine for Chronic Postoperative Pain in Adults after Cardiac Surgery
This study tests whether taking taurine and butyrate daily can reduce long-lasting pain after cardiac surgery in adults.
-
Perioperative IV nimodipine for people undergoing open colectomy for bowel cancer
This trial tests whether giving intravenous nimodipine around the time of open colectomy can reduce opioid use, lower pain, and speed early bowel recovery for people having surgery for bowel cancer.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.